Each 1 ml of vaccine contains:
Active substances:
C. perfringens type A toxoid | ≥ 0.9 U3 | |
C. perfringens type B & C (β) toxoid | ≥ 12.4 U1 | |
C. perfringens type D (ε) toxoid | ≥ 5.1 U1 | |
C. chauvoei whole culture, inactivated | meets Ph. Eur.2 | |
C. novyi toxoid | ≥ 1.2 U1 | |
C. septicum toxoid | ≥ 3.6 U1 | |
C. tetani toxoid | ≥ 2.5 U1 | |
C. sordellii toxoid | ≥ 0.8 U1 | |
C. haemolyticum toxoid | ≥ 16.5 U3 | |
1 In-house ELISA
2 Challenge test according to Ph. Eur.
3 In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes.
Adjuvant:
Alum | 3.03 – 4.09 mg Aluminium | |
Excipient:
For the full list of excipients, see section "Pharmaceutical particulars".